The hydrodistilled oil from the fruits of Bursera tomentosa, obtained in 0.2% yield, was analyzed by GC-MS. Nine components were identified, which made up 99.3% of the oil. The most abundant constituents were cis-ocimene (47.6%), n-nonane (28.2%) and germacrene-D (11.1%). The oil showed antibacterial activity against Staphylococcus aureus (ATCC 25923), Enterococcus faecalis (ATCC 29212) and Salmonella typhi (CDC 57), with MIC values of 80 μg/mL, 120 μg/mL and 100 μg/mL, respectively.
The genus Bursera (family Burseraceae) comprises about 40 species [1a-1c] . It has been reported that plants of this genus produce balm type terpenoidal resins which include mono-, sesqui-, and triterpenoids, but rarely diterpenoids [2a] . B. tomentosa is a tree, 5 to 8 meters high, with oblong, deciduous leaves, and small white flowers, clustered in panicles [2b] . The species is distributed from Central America to Colombia and Venezuela [2c, 2d] , where it is known as "Bálsamo de incienso". B. simaruba is regarded as a medicinal plant with antiinflammatory activity [3a,3b] . The essential oil of this species contains limonene, α-humulene and β-caryophyllene. On the other hand, spathulenol, cadinene, elemene, germacrene B, α-pinene and αthujene have been found in B. graveolens and Protium spruceanum [3c,3d] . The present study deals with the chemical composition of the essential oil obtained from the fruits of B. tomentosa, The antibacterial activity of the oil was also assayed against Gram-negative and Gram-positive bacteria by the disc diffusion method.
The essential oil obtained by hydrodistillation of the fruits of B. tomentosa was analyzed by GC-MS. Nine compounds were identified, which made up 99.3 % of Table 2 : Antibacterial activity of the essential oil from the fruits of B. tomentosa.
Sulbactam-Ampicillin® (10 μg/10 μg), Vancomycin® (30 μg), Gentamycin® (10 μg), Aztreonam® (30 μg), Cefoperazone® (75 μg), Ciprofloxacyne® (30 μg), NA: Not active, NT: not tested.*Inhibition zone, diameter measured in mm, disc diameter 6 mm, average of two consecutive assays. MIC: Minimal inhibitory concentration, concentration range: 20 to 540 μg/mL. respectively. It did not show any activity against E. coli (ATCC 25922), K. pneumoniae (ATCC 23357), and P. aeruginosa (ATCC 27853) in the concentration range of 20 to 540 μg/mL. These results are presented in Table 2 .
The presence of cis-ocimene (47.6%), n-nonane (28.2%), germacrene D (11.1%) and n-undecane (5.5%) is associated, according to the literature, with activity against Gram-positive and Gram-negative bacteria [4a,4b] . According to Daíse 4d] , the minor constituents limonene (3.5 %), γ-cadinene (1.2 %), t-cadinol (1.1%), caryophyllene (0.6 %) and trans-ocimene (0.5 %) also contribute to the antibacterial activity when present in an oil. This is the first report on the antibacterial activity of the essential oil from the fruits of B. tomentosa. 
Experimental

Isolation of essential oil:
Fruits of B. tomentosa (1 Kg) were cut into small pieces and subjected to hydrodistillation for 3 h, using a Clevenger-type apparatus to yield 2.0 mL of oil. This was dried with anhydrous Na 2 SO 4 , and stored in the refrigerator at 4°C under N 2 .
Gas chromatography: GC analysis was performed on a Perkin-Elmer AutoSystem gas chromatograph equipped with a flame ionization detector. Two capillary columns of different polarities were used: a 5% phenylmethyl polysiloxane capillary fused-silica column (HP-5M, Hewlett Packard, USA) 30 m x 0.25 mm, film thickness 0.25 μm, and a polyethylene glycol capillary fused-silica column (AT-WAX, Alltech Associates Inc., Deerfield, IL) of the same dimensions. The initial oven temperature was 60°C. This was then raised to 260°C at 4°C/min, and the final temperature maintained for 20 min. The injector and detector temperatures were 200°C and 250°C, respectively. The carrier gas was helium at 1.0 mL/min. The sample was injected using a split ratio of 1:100. Retention indices were calculated relative to C 8 -C 24 n-alkanes, and compared with values reported in the literature [5a-5c] .
Gas chromatography-mass spectrometry:
The GC-MS analyses were carried out on a Hewlett Packard GC-MS system, Model 5973, fitted with a 30 m long, crosslinked 5 % phenylmethyl siloxane (HP-5MS, Hewlett Packard, USA) fused-silica column (0.25 mm, film thickness 0.25 μm). Source temperature 230°C; quadrupole temperature 150°C; carrier gas helium, adjusted to a linear velocity of 34 m/s; ionization energy, 70 eV; scan range 40-500 amu; 3.9 scans/s. The injected volume was 1.0 μL of a 2% solution of the oil in ether. A Hewlett-Packard ALS injector was used with split ratio 1:100. The identification of the oil components was based on the Wiley MS Data Library (6 th edn), followed by comparison of MS data with published literature [5c,5d] .
Microbiological analysis:
The bacterial strains used for testing were Staphylococcus aureus (ATCC 25923), Enterococcus faecalis (ATCC 29212), Escherichia coli (ATCC 25922), Pseudomonas aeruginosa (ATCC 27853), Klebsiella pneumoniae (ATCC 23357) and S. typhi (CDC 57).
Antibacterial method:
The antibacterial activity was evaluated according to the disc diffusion assay described by Velasco et al. [5e] . The strains were maintained in agar kept at room temperature. Every bacterial inoculum (2.5 mL) was incubated in Mueller-Hinton broth at 37ºC for 18 h. The bacterial inoculum was diluted in sterile 0.85% saline solution to obtain a turbidity visually comparable to a McFarland Nº 0.5 standard (10 6-8 CFU/mL). Every inoculum was spread over plates containing Mueller-Hinton agar and a paper filter disc (diameter 6 mm) saturated with 10 μL of Essential oil of Bursera tomentosa, Natural Product Communications Vol. 5 (2) 2010 313 essential oil. The plates were left for 30 min at room temperature and then incubated at 37ºC for 24 h. The inhibitory zone around the disc was measured and expressed in mm. A positive control was also assayed to check the sensitivity of the tested organisms using the following antibiotics: Sulbactam-Ampicillin® (10μg/10 μg), Vancomycin® (30 μg), Gentamycin® (10 μg), Cefoperazone® (75 μg), Ciprofloxacyne® (30 μg) and Aztreonam® (30 μg) ( Table 2 ). The minimal inhibitory concentration (MIC) was determined only with microorganisms that displayed inhibitory zones. MIC was determined by dilution of the essential oil in dimethylsulfoxide (DMSO) pipetting 10 μL of each dilution onto a filter paper disc. Dilutions of the oil within a concentration range of 20-540 μg/mL were also tested. MIC was defined as the lowest concentration that inhibited the visible bacterial growth [5f]. A negative control was also included in the test using a filter paper disc saturated with DMSO to check possible activity of this solvent against the bacteria assayed. The experiments were repeated at least twice.
